Opinion
Video
Author(s):
Dr Linhares discusses newer combination therapies for the treatment of patients with chronic lymphocytic leukemia, highlighting ibrutinib and venetoclax, which is being studied in the CAPTIVATE trial.
Four Things to Remember When Both Spouses Have Cancer
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
The Treatment Journey of a Patient with CLL
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
Brukinsa May Improve Efficacy Versus Imbruvica in R/R CLL and SLL